Cystic Fibrosis for Carrier
Cystic fibrosis (CF) for carrier screening
EDTA peripheral blood
Storage and stability information:
Room temperature,1 week
Once per week
PCR, Bead array
Negative for mutations analyzed.
The clinical indication for this test is to screen for CF carrier status in individuals during the preconception or prenatal period. This assay is performed with the Luminex IVD CF60 bead array method; the assay detects 60 clinically relevant mutations, which include the mutation panel recommended by ACMG/ACOG, and additional mutations allowing improved carrier detection among the African American and Hispanic populations.